+91-9660032889
+91-9660032889
support@mysiponline.com
-
₹9.76
(-0.06%)
Current NAV 07-07-2025
-
0%
Returns
-
Min. SIP ₹500
Min. Investment ₹500
Fund Suitability Test
Asset Allocation (As on 31-May-2025)
Allocation of Equity and Debt Asset Classes.
- Equity 95.48%
Market Cap Allocation Of Equity
Shows Distribution among Different Size Companies.
| Category | Allocation |
|---|---|
| Small Cap | 32.83 |
| Large Cap | 31.41 |
| Mid Cap | 31.23 |
Sector Allocation of Equity
Weightage of Portfolio Among Different Sectors.
Healthcare
Consumer Defensive
Basic Materials
Financial Services
Current Stocks Holdings of Equity
Information on Stock Holdings in Portfolio
| Stocks | Market Cap | Sectors (PE Ratio) 08-Jul-2025 |
Holdings | PE Ratio 08-Jul-2025 |
1Y Return |
|---|---|---|---|---|---|
| Divi's Laboratories Ltd | Large Cap | Healthcare (39.49) | 8.71% | 83.38 | 48.69% |
| Sun Pharmaceuticals Industries Ltd | Large Cap | Healthcare (39.43) | 7.82% | 36.72 | 7.51% |
| Cipla Ltd | Large Cap | Healthcare (39.43) | 6.61% | 22.83 | 0.23% |
| Apollo Hospitals Enterprise Ltd | Mid Cap | Healthcare (47.82) | 5.86% | 75.24 | 19.75% |
| Dr Reddy's Laboratories Ltd | Large Cap | Healthcare | 3.52% | - | 0% |
| Piramal Pharma Ltd | Small Cap | Healthcare (22.59) | 3.5% | 0 | -26.02% |
| Biocon Ltd | Mid Cap | Healthcare (39.43) | 3.43% | 48.75 | 0.76% |
| Emcure Pharmaceuticals Ltd | Small Cap | Healthcare | 3.4% | - | 0% |
| Glenmark Pharmaceuticals Ltd | Mid Cap | Healthcare (39.43) | 2.81% | 49.17 | 34.49% |
| Neuland Laboratories Ltd | Small Cap | Healthcare (39.43) | 2.76% | 57.71 | 52.7% |
| Syngene International Ltd | Mid Cap | Healthcare (53.03) | 2.65% | 52.45 | -9.02% |
| GlaxoSmithKline Pharmaceuticals Ltd | Mid Cap | Healthcare (39.43) | 2.63% | 59.75 | 29.54% |
| Torrent Pharmaceuticals Ltd | Large Cap | Healthcare (39.43) | 2.42% | 58.77 | 15.4% |
| Abbott India Ltd | Mid Cap | Healthcare (39.43) | 2.33% | 0 | 23% |
| Pfizer Ltd | Small Cap | Healthcare (39.49) | 2.24% | 0 | 26.48% |
| Ipca Laboratories Ltd | Mid Cap | Healthcare (39.43) | 2.24% | 50.41 | 23.2% |
| Sanofi Consumer Healthcare India Ltd | Small Cap | Healthcare | 2.08% | - | 0% |
| Rainbow Childrens Medicare Ltd | Small Cap | Healthcare (47.82) | 2.01% | 64.21 | 19.63% |
| Zydus Wellness Ltd | Small Cap | Consumer Defensive (67.94) | 1.94% | 183.97 | 7.22% |
| Dr. Lal PathLabs Ltd | Small Cap | Healthcare (47.82) | 1.9% | 49.47 | -1.06% |
| Vijaya Diagnostic Centre Ltd | Small Cap | Healthcare (47.82) | 1.84% | 71.76 | 27.79% |
| Fortis Healthcare Ltd | Mid Cap | Healthcare (47.82) | 1.72% | 76.92 | 73.14% |
| Hindustan Unilever Ltd | Large Cap | Consumer Defensive (38.82) | 1.58% | 0 | 0% |
| Shaily Engineering Plastics Ltd | Small Cap | Basic Materials (44.4) | 1.56% | 78.85 | 77.61% |
| Alkem Laboratories Ltd | Mid Cap | Healthcare (38.82) | 1.52% | 57.92 | -8.63% |
| Orchid Pharma Ltd | Small Cap | Healthcare (39.49) | 1.38% | 37.62 | -35.32% |
| Emami Ltd | Small Cap | Consumer Defensive (58.55) | 1.37% | 31.08 | -23.34% |
| Medi Assist Healthcare Services Ltd | Small Cap | Healthcare (111) | 1.35% | 42.56 | 2.77% |
| Medplus Health Services Ltd | Small Cap | Healthcare (39.43) | 1.34% | 67.84 | 26.7% |
| Jubilant Pharmova Ltd | Small Cap | Healthcare (55.16) | 1.28% | -300.03 | 96.3% |
| Alembic Pharmaceuticals Ltd | Small Cap | Healthcare (39.43) | 1.27% | 33.65 | 1.39% |
| Max Healthcare Institute Ltd Ordinary Shares | Mid Cap | Healthcare (47.82) | 1.23% | 117.57 | 40.53% |
| Lupin Ltd | Mid Cap | Healthcare (132.95) | 1.2% | 167.31 | 197.56% |
| Marico Ltd | Mid Cap | Consumer Defensive (101.43) | 1.18% | 23.47 | -0.76% |
| AstraZeneca Pharma India Ltd | Small Cap | Healthcare (55.16) | 1.13% | 96.24 | 61.67% |
| Mankind Pharma Ltd | Mid Cap | Healthcare (39.43) | 1.12% | 50.27 | 17.68% |
| Aurobindo Pharma Ltd | Mid Cap | Healthcare (39.43) | 0.89% | 19.05 | -12.37% |
| Nestle India Ltd | Large Cap | Consumer Defensive (67.77) | 0.75% | 72.81 | -5.89% |
| Neogen Chemicals Ltd | Small Cap | Basic Materials (58.97) | 0.49% | 86.21 | -3.2% |
| PB Fintech Ltd | Mid Cap | Financial Services (76.58) | 0.44% | 615.37 | 84.19% |
| Colgate-Palmolive (India) Ltd | Mid Cap | Consumer Defensive (56.87) | 0% | 0 | -15.32% |
Discover More with Premium Access
View Stock Information
Take test again
Chat with usFrequently Asked Questions
What is Market cap allocation in the portfolio?
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.
Top 5 holdings for Bajaj Finserv Healthcare Fund ?
The top holdings of this fund are
How do I create a good mutual fund portfolio?
Building a good portfolio requires proper research and knowing about goals that need to be achieved. Set a boundary for your risk capacity, study about different funds and look at its past performance. Balance portfolio according to set goals and stay informed.
How to maintain a good portfolio?
Timely monitoring of the portfolio keeps us aware of the changes in the ongoing market trends. It helps in making plans for any policy change.
What is sector allocation in the portfolio?
The distribution of assets among various economic sectors is referred to as sector allocation in a portfolio. These sectors include technology, healthcare, financial, energy, and many others.
Top 5 Sector for Bajaj Finserv Healthcare Fund ?
The major sectors of this fund are .
What is the ideal number of funds to have in a portfolio?
There is no ideal number, but it is always advisable to keep 4-5 funds in the portfolio as it can be easy to manage them and correct decisions can be taken according to it. Diversification is the key to manage and balance your portfolio for smooth growth.
How does risk tolerance play a role in determining portfolio allocation?
Risk tolerance is an important factor in maintaining portfolio allocation. With the correct mix of assets, the value of investments can improve significantly.
